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Portable biosensor systems would beneﬁt from reduced dependency on external power supplies as well
as from further miniaturization and increased detection rate. Systems built around self-propelled
biological molecular motors and cytoskeletal ﬁlaments hold signiﬁcant promise in these regards as they
are built from nanoscale components that enable nanoseparation independent of ﬂuidic pumping.
Previously reported microtubule-kinesin based devices are slow, however, compared to several existing
biosensor systems. Here we demonstrate that this speed limitation can be overcome by using the faster
actomyosin motor system. Moreover, due to lower ﬂexural rigidity of the actin ﬁlaments, smaller features
can be achieved compared to microtubule-based systems, enabling further miniaturization. Using a
device designed through optimization by Monte Carlo simulations, we demonstrate extensive myosin
driven enrichment of actin ﬁlaments on a detector area of less than 10 μm2, with a concentration half-
time of approximately 40 s. We also show accumulation of model analyte (streptavidin at nanomolar
concentration in nanoliter effective volume) detecting increased ﬂuorescence intensity within seconds
after initiation of motor-driven transportation from capture regions. We discuss further optimizations of
the system and incorporation into a complete biosensing workﬂow.
& 2013 Elsevier B.V. All rights reserved.1. Introduction
Portable biosensors with increased sensitivity, rate of detection
and capacity for multiplexing (Giljohann and Mirkin, 2009; Jokerst
et al., 2010; Ng et al., 2010) are of appreciable interest for
improved point-of-care medical diagnostics and related applica-
tions. Realizations of high-performance devices have been pro-
posed using nanostructures (Giljohann and Mirkin, 2009; Lee
et al., 2004; Nam et al., 2003; Zhang et al., 2005a, 2005b)
combined with microﬂuidics/nanoﬂuidics for speciﬁc concentra-
tion of analytes from a complex sample mixture (Jokerst et al.,
2010; Ng et al., 2010; Whitesides, 2006). However, particularly
nanoﬂuidics requires strong driving forces for liquid transport
(Månsson et al., 2005), and depends on bulky accessory equipment
such as pumps and various control devices (Jokerst et al., 2010;
Whitesides, 2006). One way to circumvent these problems would
be to use Adenosine-5'-triphosphate (ATP)-driven biological mole-
cular motors for separation and concentration of analyte mole-
cules on detector sites (Fischer et al., 2009; Korten et al., 2010;ll rights reserved.
+46 480 446 262.
.Lin et al., 2008). In this process, the analyte molecules are linked to
motor-propelled cytoskeletal ﬁlament shuttles (Bachand et al.,
2006; Brunner et al., 2007; Hess et al., 2001; Månsson et al.,
2004; Ramachandran et al., 2006) and guided on nanopatterned
surfaces (Ashikari et al., 2012; Bunk et al., 2005b; Byun et al., 2007;
Hess et al., 2001; Nicolau et al., 1999; Sundberg et al., 2006b;
Suzuki et al., 1997) to the desired sites. In addition to advantages
over microﬂuidics driven separation, the actual detection of
analytes may be achieved in unique ways using motor driven
devices e.g. by the actual observation of cotransportation of
ﬁlaments and analytes (e.g. Korten et al., 2013). One automated
approach that combines this unique biosensing principle with
separation is transportation of analytes to a pre-determined
detection site that can be readily reached only by motor driven
transportation. Whereas proof-of-principle devices of this type
have been reported using the microtubule-kinesin motor system
(Fischer et al., 2009; Lin et al., 2008) these devices have shown
orders of magnitude, lower rates of detection than other high-
sensitivity methods (Georganopoulou et al., 2005; Mulvaney et al.,
2009; Nam et al., 2003; Rissin et al., 2010).
A way to overcome the limitations in speed may be to use
myosin-propelled actin ﬁlaments that are ten-fold faster than
kinesin-propelled microtubules. This idea is supported by the
recent demonstration of consistent heavy meromyosin (HMM)
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complexes (Kumar et al., 2012). Moreover, the low ﬂexural rigidity
(Vikhorev et al., 2008a) of actin ﬁlaments compared to micro-
tubules would enable more extensive miniaturization that may
also contribute to further increased detection rate. We thus
hypothesize that actin ﬁlaments can be concentrated by myosin
driven transport, orders of magnitude faster than in previous
motor driven devices (Fischer et al., 2009; Lin et al., 2008).
Moreover, we expect that the use of actin ﬁlaments allows further
miniaturization, e.g. of the detector site, with favorable effects on
the signal/noise ratio (Katira and Hess, 2010b). With the aim to
test these ideas, we ﬁrst present experiments using a generic
concentrator device to validate a Monte-Carlo simulation approach
(Nitta et al., 2006, 2008) that is then used for rational design of
an optimized device. Experiments employing the latter device
showed rates of concentration that were nearly two orders of
magnitude faster than in earlier motor-driven devices but also
faster than key ampliﬁcation steps in non-motor based diagnostic
tests (Georganopoulou et al., 2005; Nam et al., 2003). Moreover,
further miniaturization compared to microtubule-kinesin devices,
allowed actin ﬁlament capture and subsequent guidance to detec-
tor site of less than 10 μm2 total area. We discuss further
optimizations and the most effective incorporation of the tested
device into complete workﬂows for high-sensitivity detection of
analytes in, for example, clinical diagnostics and environmental
monitoring.2. Materials and methods
2.1. Nanostructuring and surface preparation
An SiO2 layer of 825 nm thickness was grown by wet thermal
oxidation on a Si wafer followed by covering with lift-off resist
(LOR 0.7A; Microchem Corporation, Newton, MA, USA) using spin
coating at 1500 RPM for 30 s and subsequent baking at 180 1C for
15 min on a hot plate. Next, polymethylmethacrylate, (PMMA
950A5; Microchem Corporation, Newton, MA, USA)
was spin-coated on top at 6000 RPM for 60 s, followed by baking
at 160 1C for 15 min. This PMMA resist layer was exposed by
electron-beam lithography (EBL; Raith 150, Dortmund, Germany)
giving top line widths of approximately 185 nm in the PMMA. The
PMMA was then developed with methyl isobutyl ketone and
isopropanol (MIBK:IPA; Merck KGaA, Darmstadt, Germany) at a
ratio of 1:3 for 1 min, followed by rinsing with IPA for 30 s. Next,
the sample was subjected to O2 plasma ashing in a Plasma Preen at
5 mBar for 15 s. Then, the LOR layer was etched with MF-319:H2O
(Microposit MF-319 Developer, Rohm and Haas Electronic Materi-
als, Coventry, UK) in the ratio 1:1 for 4 min and rinsed with H2O
for 30 s to halt etching. The resulting width of the bottom
channel was 260 nm, with an under-cut of approximately 40 nm
from the opening of the top channel (Fig. 1b). The sample was then
treated with another plasma ashing step at 5 mBar for 15 s in
order to remove possible LOR residue on the bottom of the
channel and making the PMMA hydrophilic and thereby incapable
of supporting motility. Finally, the sample was silanized, in a
chemical vapor phase deposition (CVD) process (Bunk et al.,
2005a; Sundberg et al., 2003), with trimethylchlorosilane (TMCS,
497%, GC, Sigma-Aldrich, Sweden AB, Stockholm, Sweden) in a
closed glass container inside a glove box, with sub-ppm levels of
O2 and H2O. As a ﬁnal step before the in vitro motility assay
procedure, the sample was steamed in a deionized water bath for
30 s to wet the channels and remove possible air bubbles. The
surfaces were rinsed in distilled water for 10 min prior to use.
The above account describes the key steps in producing the
ﬁrst generation concentration device. The second-generationconcentration device was fabricated in a similar way but without
any LOR layer (Fig. 4a).
2.2. Protein preparations and in vitro motility assays
Myosin II was puriﬁed from rabbit fast skeletal muscle (Sata
et al., 1993) and then digested by α-chymotrypsin to yield HMM
(Kron et al., 1991). Actin ﬁlaments were prepared from rabbit
skeletal muscle (Pardee and Spudich, 1982) and ﬂuorescently
labeled with Alexa Fluor 488s phalloidin (APh) or tetramethylr-
hodamineisothiocyanate (TRITC)–phalloidin (RhPh; Molecular
Probes Invitrogen, Eugene, OR) (Balaz and Mansson, 2005).
Flow cells were constructed from one cover-slip and one
nanostructured chip on top with double-sided sticky tape as
spacers. All solutions that were added to the ﬂow cell were based
on buffer A (1 mM MgCl2, 10 mM 3-(N-morpholino)propanesulfo-
nic acid MOPS, 0.1 mM K2-ethylene glycol tetraacetic acid (EGTA),
pH 7.4) and all proteins were diluted in buffer B (buffer A with
1 mM dithiothreitol (DTT) and 50 mM KCl). The ﬂow cell was pre-
incubated essentially as described previously (Kron et al., 1991;
Sundberg et al., 2006b): (i) HMM (120 μg mL−1) for 4 min, (ii)
bovine serum albumin (BSA; 1 mg mL−1) for 1 min, (iii) blocking
actin (1 μM unlabeled sheared actin ﬁlaments with 1 mM MgATP)
for 2 min. These pre-incubation steps were followed by (iv) wash
with a50 assay solution (buffer A with 10 mM DTT, 1 mM MgATP,
35 mM KCl, ionic strength 50 mM) and (v) addition of actin
ﬁlaments at 10 nM (second generation) or 100 nM (ﬁrst genera-
tion). After an incubation period of 1 min, ﬂow cells were washed
with buffer B and (vi) incubated with rigor solution (r60) for initial
observation in the microscope. The latter solution had the same
composition as the a50 solution but without MgATP and with 45 mM
instead of 35 mM KCl, giving an ionic strength 60 mM.
An anti bleach mixture of 3 mg mL−1 glucose, 100 μg mL−1 glucose
oxidase and 870 UmL−1 catalase was added. Soon after the recording
was started, ﬂow cells were (vii) incubated with a60 solution (r60
with 1 mM MgATP and an ATP re-generating system: 2.5 mM
creatine phosphate and 3.5 U mL−1 creatine phosphokinase). For
the second generation concentrator device the procedure was similar
as described above, but the incubation step with block actin and
subsequent washing steps (steps iii and iv) were omitted.
To demonstrate analyte concentration we rinsed the second
generation device after previous use with (i) a130 solution (similar
to a60 but with an ionic strength of 130 mM) and (ii) buffer B
before incubation with (iii) 10 nM biotinylated APh labeled actin
ﬁlaments for one minute. The ﬂow cell was then rinsed with (iv)
buffer B and, incubated with (v) TRITC–streptavidin (2 nM) for one
minute. To block remaining sites on streptavidin and avoid cross-
linking of ﬁlaments via streptavidin–biotin links, the ﬂow cell was
then rinsed with (vi) biotin (30 μM). Subsequently, (vii) buffer B
was infused. Flow cells were then incubated with (viii) r60
solution and observed in the microscope before motility was
induced by (ix) addition of a60 solution.
2.3. Data collection and analysis of in vitro motility assays
Fluorescently labeled actin ﬁlaments were observed using
a Nikon Eclipse TE300 inverted ﬂuorescence microscope (Nikon
Corporation, Tokyo, Japan) equipped with a temperature-regulated
Nikon (100 1.4 NA) oil immersion objective and TRITC (Ex. 540/
25, DM 565, and BA 605/25) and FITC (Ex. 465–495, DM 505, and
BA 515–555) ﬁlter sets. A cooled Hammamtsu EMCCD camera
(C9100-12) was used to record image sequences (Persson et al.,
2010) which were then analyzed using algorithms developed in
the MATLAB (Mathworks Inc., Natick, MA; Mansson and Tagerud,
2003). Image sequences were further analyzed using Image J
(Rasband, W.S., ImageJ, U S National Institutes of Health, Bethesda,
Fig. 1. Experiments using ﬁrst generation concentrator device: (a) Design (resist mask): trapping zone (TZ), 3 control loading zones (CTR-LZ) and 3 loading zones
connected to trapping zone (CON-LZ) via nanochannels. Pink: functional HMM. White dashed lines indicate symmetery lines delimiting areas for Monte-Carlo simulations
(Supporting Methods; Fig. S1). Scale bar: 20 μm. (b) Scanning electron micrograph of nano-sized channel. Scale bar: 100 nm. (c) Ratio between background-subtracted
intensities: CON-LZ/CTR-LZ vs. time. Red noisy curve: early after MgATP addition. Red straight line: steady-state. Blue: fraction of ﬁlaments in CON-LZ in Monte-Carlo
simulations. (d) Fluorescence micrographs showing TRITC-phalloidin labeled actin ﬁlaments and autoﬂuorescent LOR at times corresponding to black arrows in c. Before
MgATP addition (0.2 s), actin ﬁlaments also bound to PMMA. Temperature: 22 1C. Image enhancement by histogram stretching. Scale bar: 10 μm. Red shapes: appropriate
detector locations. (e) Filament accumulation on TZ according to Eq. (1) and c (same color code as c) or measured (black) from intensity ratio TZ/CTR-LZ. Star, same data point
as star in f. Dashed blue line: Monte-Carlo model including delay due to transport along nano-sized track between CON-LZ and TZ and (f) intensity ratio TZ/CTR-LZ at steady-
state, different times after MgATP addition. Similar temperature and motility quality (fraction of motile ﬁlaments [470%], velocity [4 μm/s]) as at t¼1 min. Straight line:
regression line with 95% conﬁdence interval (dashed lines). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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the area of interest (trapping zone, connected loading zone or
control loading zone, Fig. S1) followed by measurements of the
mean intensity for each frame. The mean ﬂuorescence intensities
in the connected loading zone and trapping zone were ﬁrst
background subtracted followed by division with the mean back-
ground subtracted intensity of the control loading zone in the
same frame (to correct for photobleaching). The background
intensity levels in these analyses were obtained as the average
intensity of seven ﬁlament free regions of interest observed 300 s
after onset of illumination.3. Results and discussion
3.1. First generation device
A biosensing principle that is unique to molecular motors and
cytoskeletal ﬁlaments, is detection based on co-transportation of
analytes and cytoskeletal ﬁlaments conjugated with antibodies or
other recognition molecules (discussed in Korten et al. (2013);Månsson et al. (2012b)). This approach is here enhanced by a
concentration scheme for increased S/N ratio and automation.
As a basis for later rational design we ﬁrst tested a device were
actin ﬁlaments were captured by HMM (pink; Fig. 1a) adsorbed
to relatively large TMCS-derivatized loading zones (Bunk et al.,
2005b; Sundberg et al., 2006b). Upon ATP addition, the ﬁlaments
were transported from these zones along nano-sized channels
(Fig. 1b) to a trapping zone (detector area). The guidance of actin
ﬁlaments along channels is more challenging (Nitta et al., 2008;
Sundberg et al., 2006b; Vikhorev et al., 2008a, 2008c) than for
microtubules due to low ﬂexural rigidity. We thus used nanos-
tructuring (EBL) for fabrication of guiding channels to make them
narrow enough to prevent ﬁlament U-turns. In addition we used
three pairs of rectiﬁers (Hiratsuka et al., 2001; van den Heuvel
et al., 2005; Vikhorev et al., 2008c) (total measured rectiﬁcation
96%) along each channel (Fig. 1a,b). In view of the previously
demonstrated similarity in motility quality for Rh–Ph labeled
ﬁlaments and for ﬁlaments transporting antibody–antigen com-
plexes (Kumar et al., 2012) the concentrator performance was
studied quantitatively using Rh–Ph labeled ﬁlaments, for optimal
image quality.
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between loading zones connected to trapping zones (CON-LZ;
Fig. 1a) and control loading zones (CTR-LZ) without such connec-
tion, reports the approximate change in the number of ﬁlaments
on the connected loading zones corrected for photobleaching, (see
further Fig. S2). This ratio decreased (Fig. 1d, Movie S1) with an
exponential time course that was well reproduced (Fig. 1c) by
Monte-Carlo simulations for a similar geometry and ﬁlament
sliding velocity (details below). The expected ratio between
average ﬁlament density in the trapping zone at inﬁnite time (at
steady-state; CTSS) and at time 0 s (Ci) is given by (Supporting
Information Results and Discussion):
CTSS
Ci
≈
kþf
ðkþ þ kÞ
AL
AT
þ 1
 
ð1Þ
Here, the quantities k+ and k− are rate constants of ﬁlament-
transitions from the loading zone and trapping zone, respectively.
Further, f is the fraction of motile ﬁlaments and AL and AT is the
area of the connected loading zones and the trapping zone,
respectively. For the experiment in Fig. 1, with 3 connected loading
zones, AL/AT≈3438 μm2/123 μm2≈27.9 and kþf =ðkþ þ kÞ≈0:7 (1-
fraction of ﬁlaments remaining in connected loading zones at
steady-state; straight line in Fig. 1c). From Eq. (1) and the observed
time course in Fig. 1c the number of ﬁlaments in the trapping zone
is predicted to increase as indicated by the red line in Fig. 1e to a
steady-state value about 20 times the initial value. This is about 10
times larger than the observed increase (2.470.2 times; n¼5;
black line in Fig. 1e), a difference that we attribute to loss of
ﬁlaments (Fig. S3) from the trapping zone at high ﬁlament
densities. That similar detachment of ﬁlaments from the trapping
zone did not occur at moderate and low ﬁlament densities is
indicated by a nearly constant intensity ratio between trapping
zone and control loading zone for 420 min after attainment of
steady-state (Fig. 1f).
The detachment and the associated deviation between experi-
ments and simulations are likely to be seriously aggravated by the
presence of blocking actin. The blocking actin ﬁlaments are not
ﬂuorescence labeled and added at about 1 μM prior to addition of
ﬂuorescence labeled actin ﬁlaments (added at nannomolar con-
centrations). The purpose is to block rigor HMM heads that may
otherwise interfere with the transportation of ﬂuorescent actin
ﬁlaments but a large fraction of the blocking actin ﬁlaments are
actually motile (Sundberg et al., 2006a) and will compete with
ﬂuorescent ﬁlaments for HMM binding sites. The competition is
particularly severe when the ﬁlaments become enriched in the
trapping zone, emphasizing the importance of omitting blocking
actin when using nanostructured concentration devices. This is
also done in the tests below.
The ﬁlament density distribution in the trapping zone was
spatially non-uniform (Fig. 1d) with 2.770.3 times (mean7-
standard error of the mean [SEM]; n¼3) higher ﬁlament density
(from intensity data) within 1 μm from the trapping zone edge
than at the center. Filaments also exhibited high local density in
the semi-circular part of the rectiﬁer structure. This suggests that
the signal-to-noise ratio would be enhanced with detectors
located in such regions (see highlighted red regions in Fig. 1d)
and that the trapping zones may be modiﬁed to circular loops (see
below).
3.2. Monte-Carlo simulations for rational concentrator design
For cytoskeletal ﬁlaments propelled by molecular motors
on a surface without chemical or topographical patterns (ﬂat
surfaces) the instantaneous angular changes in sliding direction
are expected to be the Gaussian with mean 0 rad and standard
deviation, SD¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃvfΔt=LPp where vf is the sliding velocity, Δt is thetime interval between subsequent updates in sliding direction and LP
is the ﬁlament persistence length (Duke et al., 1995; Nitta and Hess,
2005; Vikhorev et al., 2008a, 2008c). At walls, designed to guide
approaching ﬁlaments with close to 100% probability (as used here),
the random diffusion-like motion is prevented (Clemmens et al.,
2003a, 2003b; Sundberg et al., 2006b; van den Heuvel et al., 2005) as
the ﬁlaments are forced to follow the walls.
On the above grounds, we simulated the behavior of an
ensemble of actin ﬁlaments in a concentrator device similar to
that in Fig. 1 using a Monte-Carlo approach (Nitta et al., 2006,
2008). In the present study the simulations were implemented in
the Matlab with the ﬁlament behavior at the walls treated as
previously (Månsson et al., 2012a). Further details are given in the
supporting information but it is of relevance to mention here that
the loading zone shape was deﬁned by a combination of an
elliptical and triangular region (Fig. S1).
The validation of the Monte-Carlo simulation with respect to its
capability to predict the time course of the concentration process
(Fig. 1c) enables optimization of the concentrator design for speed
without time consuming and expensive experiments. This is parti-
cularly important as such experiments also suffer from difﬁculties to
follow rapid time courses. The Monte-Carlo simulations showed that
the time course of the concentration process was approximately
exponential (Figs. 1c and 3) with a half-time inversely proportional to
the sliding velocity (Fig. 2e) and directly proportional to loading zone
area (Fig. 2f). Further, a transition from nearly circular to triangular
loading zones reduces the half-time by almost one order of magni-
tude (Fig. 3b). The simulated effects of sliding velocity and loading
zone area on the concentration half-time were expected if the
ﬁlaments largely executed motor driven diffusion (Vikhorev et al.,
2008c). Thus, with a characteristic length scale r and a diffusion
constant for motor driven diffusion, D, the characteristic time, tchar, is
given by tchar¼〈r2〉/4D where D≈vf Lp (Vikhorev et al., 2008c).
Consequently, tchar would be proportional to the area and inversely
proportional to the velocity and persistence length in accordance
with the simulation results (Fig. 2e,f). The increased rate with a more
triangular shape of the loading zone, on the other hand, accords
with increased degree of ﬁlament edge-tracing (Bunk, 2005;
Månsson et al., 2012a) toward the outlet opening, i.e. an increased
ratio of ballistic to diffusion like transport (see also Nitta and Hess,
2012).
3.3. Second generation concentrator device optimized for speed and
enrichment
On basis of the simulation results, Eq. (1) and further considera-
tions above we arrived at the optimized device design in Fig. 4a,
characterized by smaller loading zones (each with 270 μm2 area)
with largely triangular shape and a circular loop (Bunk, 2005;
Sundberg et al., 2006b) as detection area. The number of loading
zones was increased to maintain high total area (AL, Eq. (1)) and the
detection area was reduced to AT≈8.5 μm2.
Upon ATP-addition, at 26–27 1C, the ﬂuorescence intensity on the
connected loading zone decreased (due to movement of actin
ﬁlaments into the detection area) with a half-time of 30 and 40 s
(Fig. 4) in two different experiments. This is considerably longer than
the half-time in the range 10–14 s (95% conﬁdence interval [CI];
degrees of freedom: 4) predicted by the Monte-Carlo simulations
for the average sliding velocity (mean7SEM: 6.7970.18 μm/s;
n¼90) measured from smoothly sliding ﬁlaments during the ﬁrst
minutes after ATP infusion. We attribute this discrepancy to average
ﬁlament velocities and path persistence lengths that are lower in
the experiments than the values of 6 μm/s (see above) and 10 μm
(Vikhorev et al., 2008b) used in the simulations. These lower values
may be due to rigor myosin heads causing temporary stops of a
fraction of the ﬁlaments or pinning of sliding ﬁlaments causing
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Fig. 3. Simulated time courses of emptying of loading zone and feeding into track to central trapping zone. Filled symbols, simulated data using the Monte-Carlo
approach. Lines, non-linear regression ﬁts to single exponentials: (a) Effects of loading zone area and (b) effects of the part of the loading zone area that is triangular (Atr; cf.
Fig. S4) relative to total area of loading zone (Atot; similar for all cases). Simulated velocity, 10 μm s−1.
Fig. 2. Monte Carlo simulations of concentrator device performance: (a) Example paths (3 ﬁlaments; velocity, 10 μm/s; 120 s) in Monte-Carlo simulations of relevant
regions in a concentrator device similar to that in Fig. 1a but with 6 symmetrically connected loading zones. Modeled ﬁlament paths reﬂected in symmetry lines indicated by
dashed orange lines corresponding to white dashed lines in Fig. 1a. (b–d) Close-up views of areas delimited by dashed rectangles in a. Red shapes: suitable detector locations.
(e) Simulated half-times (t1/2) of loading-zone emptying vs. velocity (loading zone area: open symbols, 209 μm2; ﬁlled symbols, 836 μm2). Inset: rate constants (ln 2/t1/2) vs.
velocity. Persistence length 10 μm. (f) Simulated half-times (t1/2) vs. area of loading zones for different velocities (vf) and ﬁlament persistence lengths (LP). Lines in (e) and
(f) are obtained by linear or non-linear regression analysis. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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(Vikhorev et al., 2008c). The fraction of such heads is likely to be
more substantial in the experiment in Fig. 4 compared to that in
Fig. 1 due to the use of blocking actin in the latter but not in the
former.
The ﬂuorescence intensity due to ﬁlaments accumulating on
the detector zone after ATP addition (Fig. 4b) indicated a more
than 20-fold increase in ﬁlament density relative to the loading
zone (Fig. 4d). This may be compared to a more than 90-fold
increase predicted by Eq. (1) on basis of total loading and trapping
zone areas, with 460% of the ﬁlaments motile and k+/(k++k−)
40.8 (approximated from experimental data). The observeddiscrepancy is attributed to loss of ﬁlaments from the trapping
zone into solution (Fig. S4). Whereas the ratio k+/(k++k−) could be
made close to 1 by adding rectiﬁer structures (see Fig. 1a) this is
not meaningful until escape into solution is eliminated. A major
reason for this type of escape is the very extensive accumulation of
ﬁlaments in the trapping zone loop (Månsson et al., 2012a)
leaving only few myosin heads for binding to each actin ﬁlament
(see detailed analysis below). The inter-ﬁlament competition for
motors is particularly problematic with a non-processive motor
such as myosin II. On the other hand, the fact that the motor is
non-processive is also the basis for the high speed and the
fast concentration. Therefore, any intervention directed to the
Fig. 4. Second generation concentrator device: (a) Device design. Blue areas with TMCS and functional HMM. White areas with PMMA and no HMM function. Motility
supporting loops at sharp peak of CTR-LZ to prevent ﬁlament escape into solution. Six connected loading zones, each with area ≈260 μm2. (b) Time courses (raw data) for
changes in average ﬂuorescence intensities of APh-labeled ﬁlaments in TZ (red), CTR-LZ (blue) and CON-LZ (green). Black dashed line: background ﬂuorescence level. Arrow:
ATP infusion (same in c and d), (c) ratio between average ﬂuorescence intensities on CON-LZ and CTR-LZ vs. time. Blue curve: single exponential equation (with time delay)
ﬁtted to the data by non-linear regression, giving decay half-time of 42 s (95% CI: 40.2–42.3 s; degrees of freedom: 1427) and (d) ratio of background-subtracted TZ and CTR-
LZ intensities normalized to the value before ATP-infusion. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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processive would also be expected to reduce the velocity and
concentration rate. Instead, it seems important to use overhanging
channel roofs (Bunk et al., 2005a) partly implemented in the ﬁrst-
generation device. However, the second generation device did not
use such roofs, since we omitted the LOR resist layer to appreciably
reduce autoﬂuorescence and thereby facilitate image analysis.
Alternatively, the entire trapping zone may be covered with a roof
(Lin et al., 2008). Another useful approach may be to reduce the
number of actin ﬁlaments on the loading zone by using a magnetic
pre-concentration step (also used in e.g. bio-barcode method
(Nam et al., 2003)). Here, the analyte would ﬁrst be captured on
magnetic nanoparticles with speciﬁc antibodies followed by cross-
linking to actin ﬁlaments with antibodies against another part of
the analyte. Next, only actin ﬁlaments cross-linked to a magnetic
particle will be guided toward the surface using a magnetic ﬁeld.
If magnetic nanoparticles are used, myosin driven transport would
be little affected (Persson et al., 2013), particularly at low analyte
binding.
It is of interest to estimate the maximum possible packing
density for actin ﬁlaments in the detector area. For instance, with a
trapping zone as in Fig. 4 (radius¼5 μm), a channel width of
270 nm and an actin ﬁlament diameter of 10 nm, the maximum
possible length of the trapped actin ﬁlaments would be 2 π
5 μm270 nm/10 nm¼848 μm. If the average ﬁlament length is
in the range 2–5 μm this would correspond to 170–420 ﬁlaments,
completely covering the surface. However, if space is required for
the myosin heads along the side of an actin ﬁlament, as indicated
by electron microscopy images of actin ﬁlaments with bound
HMM (Katayama, 1998), then each ﬁlament is more likely to
occupy a width of about 30 nm. This would give room for only
nine ﬁlaments side by side (compared to a maximum of fourobserved; from intensity data) corresponding to a total ﬁlament
length of 283 μm, i.e. 57–141 ﬁlaments. Importantly, the theore-
tical concentration maximum according to Eq. (1) can only be
reached if the initial number of motile ﬁlaments on the loading
zone is smaller than the maximum number of ﬁlaments that can
be packed into the trapping zone. Further, the degree of concen-
tration of analyte in the detector area will also be appreciably
reduced if only a fraction of the motile ﬁlaments have bound
analyte. This would be the case with low analyte concentration in
solution if no magnetic pre-concentration is used, again empha-
sizing the importance of such a step.
At relatively high, nanomolar analyte concentrations, on the
other hand, magnetic pre-separation is not required. Accordingly,
we show effective concentration and detection of a model analyte
(ﬂuorescent streptavidin) at nanomolar concentration. A solution
with streptavidin (2 nM) was ﬁrst added to biotinylated actin
ﬁlaments bound to HMM on the loading zone surface (incubation
for 1 min). This was followed by a number of rinsing steps before
ATP was infused. Then, a signal from the detector area, clearly
distinguished from the background noise, was obtained within
seconds (Fig. 5). We expect that most rinsing steps are omitted in a
real device operation, leading to a total time from streptavidin
infusion to detection corresponding to less than 2 min. In this
experiment, streptavidin was captured from the solution in a ﬂow
cell of 100 μm height. The area, A, parallel to the ﬂow-cell surface
where diffusion equilibration occurs within time t is approximated
as A¼π4Dt where D≈50 μm2 s−1 is the diffusion coefﬁcient of
streptavidin (Janmey et al., 1986). Now inserting, t¼60 s we obtain
A≈38,000 μm2 corresponding to a volume of 4 nl over the height of
the ﬂow cell. Thus, the described device achieves, within 2 min,
detection of attomole quantities of streptavidin corresponding to
nM concentrations in nanoliter volumes.
Fig. 5. Motor-driven concentration of streptavidin: (a) TRITC streptavidin ﬂuorescence localized mainly in central trapping zone approximately 60 s after addition of ATP.
Note minimal ﬂuorescence on connected loading zones (located as in Fig. 4a) and also low ﬂuorescence on control-loading zone (Fig. 4a), due to photo-bleaching and
(b) background-subtracted time course of increase in TRITC-streptavidin ﬂuorescence intensity on trapping zone following (i) incubation with biotinylated actin ﬁlaments on
loading zone with 2 nM streptavidin for 1 min and (ii) addition of ATP containing assay solution (at arrow). Full line represents exponential curve with a time delay (half-life:
30 s; 95% CI: 27–33 s; degrees of freedom: 498) ﬁtted to the data by non-linear regression for times o100 s.
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It is of interest to relate the detection approach in Fig. 5 to
standard immunometric methods (Wild, 2013) where recognition
molecules such as antibodies are immobilized on a solid support. In
this case, analytes captured by the immobilized antibodies are often
detected by a second antibody, speciﬁc to another epitope
of the analyte than the surface immobilized antibodies. This second
antibody may be tagged with a ﬂuorophore or an enzyme catalyz-
ing the formation of a colored product (enzyme-linked immuno-
sorbent assay; ELISA). Before the actual detection step a rinsing step
removes unbound tagged antibodies. As an alternative to the use of
a tagged antibody, all proteins in the sample may be ﬂuorescence
labeled, e.g. using standard lysine linking chemistry (Wingren et al.,
2007) before applying the sample to the surface adsorbed recogni-
tion molecules (cf. our detection of ﬂuorescent streptavidin). A
potential problem with the standard methods is false detection of
an analyte due to non-speciﬁc background ﬂuorescence e.g. due to
free ﬂuorophore or detection antibody. Highly miniaturized sensors
(nanosensors) partly circumvent this problem but the small areas
severely limits diffusion to the detector (Sheehan and Whitman,
2005). This transport problem is overcome by motor driven trans-
port (Katira and Hess, 2010b). In this connection, the use of
actomyosin allows a signiﬁcantly higher level of miniaturization
compared to previous microtubule-kinesin based devices. This
feature is facilitated by the low ﬂexural rigidity of the actin
ﬁlaments. The immobilization of the antibodies to the actin
ﬁlaments also has other advantages. First, the actin ﬁlament is a
more benign surface for antibody immobilization (Kumar et al.,
2012) than e.g. a non-biological polymer surface. Second, the
immobilization of the recognition molecule to actin ﬁlaments
separates the binding sites of analytes from the detection site. Thus,
in the initial absence of ATP the actin ﬁlaments with recognition
molecules are bound only to the large loading zone areas, as they do
not readily diffuse into the detector areas. When an analyte reaches
a loading zone by diffusion it will execute effective diffusional
search close to the surface and is likely to be swiftly captured by the
recognition molecules even if the surface is not completely ﬁlled
with antibody conjugated ﬁlaments (Berg and Purcell, 1977; Katira
and Hess, 2010a). Next, when ATP is added, the transport of actin
ﬁlaments from the loading zone to the detection zone is very rapid.
In this way, the motor driven device takes advantage of both a large
initial capture area and a small detector area for high signal-to-
noise ratio. Finally, the close temporal correlation between ATP-
addition and appearance of ﬂuorescence at the detector site is a
unique sensor mechanism that appreciably increases speciﬁcity of
motor driven devices.With regard to rate of detection, it is of interest to note that the
characteristic time for the ampliﬁcation step attributed to opti-
mized motor driven enrichment (o1 min) compares favorably to
the corresponding time (30 min) in a high-sensitivity bio-barcode
assay (Georganopoulou et al., 2005; Nam et al., 2003). This fast
time scale, by itself, increases detection accuracy because a fast
time transient removes masking by background drift. Additionally,
fast device performance minimizes any problems with unstable
biological components and also limits effects of complex ﬂuid
environments, e.g. blood serum (Korten et al., 2013). The use of the
actomyosin system could be expanded to larger cargoes (e.g.
microvesicles, bacteria etc.) by using actin bundles (Takatsuki
et al., 2010, 2011) without sacriﬁcing the high sliding speed. On
the other hand, the use of actin ﬁlaments is sufﬁcient for protein
analytes (Kumar et al., 2012; Persson et al., 2013a) and would be
advantageous for miniaturization purposes.
While awaiting important conﬁrming tests on real samples, the
described device holds considerable promise for use in point-of-
care diagnostics. This is due to the extreme miniaturization, the
independence from microﬂuidic pumping and the recent demon-
stration of actomyosin storage in an ordinary household freezer for
months (Albet-Torres and Mansson, 2011) as well as the emer-
gence of drugs that extend actomyosin shelf-life (Radke et al.,
2012). Indeed the shelf-life (Albet-Torres and Mansson, 2011;
Grove et al., 2005) for actomyosin based devices seems compar-
able to commercially available point of care test methods for e.g.
the inﬂammation marker C-reactive protein, frequently tested in
clinical practice. It is therefore also of interest to note that the
relevant plasma concentration range (nM to μM) (Pepys and
Hirschﬁeld, 2003) for this macromolecule is within reach for rapid
detection using our concentrator device.4. Conclusions
We have demonstrated rapid nanoseparation with unprece-
dented miniaturization (device area: 0.01 mm2) using an acto-
myosin driven nanoseparation device. Several key improvements
can be summarized from these results. The smaller device fea-
tures, and the associated potential for device miniaturization
compared to previously reported molecular-motor based devices
was made possible by the low ﬂexural rigidity of the actomyosin
system. The fast and speciﬁc transport of analyte molecules by the
motor system, from large capture areas to smaller concentration
regions, allows for reliable and sensitive detection, while reducing
the risk of erroneous detection. Limitations include the risk of
detachment of ﬁlaments from the concentration area upon dense
M. Lard et al. / Biosensors and Bioelectronics 48 (2013) 145–152152accumulation of ﬁlaments. This can be addressed by using a ceiling
above the detection area, which will also aid in improving the
level of concentration and detection. In a real-world application of
the concetrator device, integration of a detector into the detection
region, e.g. optical (Bunk, 2005; Lard et al., 2013) magnetoresistive
(Schotter et al., 2004) or amperometric (Gao et al., 2011), will
allow automatic read-out. In a complete point-of-care diagnostics
workﬂow, the concentrator device would most favorably be
combined with initial capture of analyte on magnetic particles
for magnetic pre-separation as in other high-sensitivity detection
methods (Nam et al., 2003). Such separation would also help
alleviate deleterious effects of body ﬂuids on actomyosin function
(Korten et al., 2013), a critical step toward the use of this method
with real samples, such as blood serum.Acknowledgments
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